NovoCure Stock Quote NVCR - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

16.9101

Bid

16.91

Ask

17.03

Volume

38,130

16.7601 Day's Range 17.04

11.29 52 Week Range 24.735

Market Cap

1.83B

Previous Close

16.86

Open

16.97

Last Trade

16.95

Last Trade Time

09:54:45

Financial Volume

$ 645,836

VWAP

16.9377

Average Volume (3m)

1,064,633

Shares Outstanding

108,201,434

Dividend Yield

PE Ratio

-8.81

Earnings Per Share (EPS)

-1.91

Revenue

509.34M

Net Profit

-207.04M

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives it... NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.novocure.com

Headquarters

Jersey, Gbr

Founded

NovoCure Ltd is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NVCR. The last closing price for NovoCure was $16.86. Over the last year, NovoCure shares have traded in a share price range of $ 11.29 to $ 24.735.

NovoCure currently has 108,201,434 shares outstanding. The market capitalization of NovoCure is $1.82 billion. NovoCure has a price to earnings ratio (PE ratio) of -8.81.

Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma

Novocure (NASDAQ: NVCR) announced today that it will present new data for its Tumor Treating Fields (TTFields) therapy for glioblastoma at the 29th Annual Scientific Meeting and Education Day of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.8299	-4.67812852311	17.74	18.165	15.35	732018	16.34906135	CS
4	0.6901	4.25462392109	16.22	18.67	15.1	909152	16.88504846	CS
12	-2.9199	-14.7246596067	19.83	21.8165	14.17	1064633	16.93150214	CS
26	-6.4999	-27.7654848355	23.41	24.4	14.17	1117932	18.52277261	CS
52	4.8901	40.6830282862	12.02	24.735	11.29	1236104	16.41185274	CS
156	-87.0899	-83.7402884615	104	120.03	10.87	1048123	40.11851425	CS
260	-73.9899	-81.397029703	90.9	232.76	10.87	982623	68.95182549	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WORXSCWorx Corporation	$ 2.50 (155.10%)	53.31M
SKKSKK Holdings Limited	$ 9.13 (100.22%)	289.21k
SPAISafe Pro Group Inc	$ 4.9815 (55.67%)	26.49M
CDTConduit Pharmaceuticals Inc	$ 0.1375 (48.97%)	304.36M
CRNCCerence Inc	$ 4.0098 (42.19%)	3.68M
PYXSPyxis Oncology Inc	$ 1.9996 (-47.65%)	5.07M
KURAKura Oncology Inc	$ 9.86 (-38.03%)	2.72M
BLRXBioLineRx Ltd	$ 0.3604 (-33.90%)	3.54M
TMTCTMT Acquisition Corporation	$ 4.704 (-26.96%)	6.97k
SLXNSilexion Therapeutics Corporation	$ 0.2505 (-24.80%)	1.67M
CDTConduit Pharmaceuticals Inc	$ 0.138724 (50.30%)	310.12M
AKTSAkoustis Technologies Inc	$ 0.10 (14.81%)	150.74M
NVDANVIDIA Corporation	$ 146.97 (0.74%)	91.68M
WORXSCWorx Corporation	$ 2.50 (155.10%)	54.21M
PETWag Group Company	$ 0.2207 (5.05%)	35.75M